# Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder

> **NCT00807248** · PHASE2 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 490 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Escitalopram placebo
- **DRUG:** Gaboxadol placebo
- **DRUG:** Escitalopram 20 mg
- **DRUG:** Gaboxadol 5 mg
- **DRUG:** Gaboxadol 10 mg

## Key facts

- **NCT ID:** NCT00807248
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-12
- **Final completion:** 2010-02
- **Target enrollment:** 490 (ACTUAL)
- **Last updated:** 2012-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00807248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00807248, "Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00807248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*